There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Flora Growth (FLGC – Research Report) and RenovoRx (RNXT – Research Report) with bullish sentiments.
Flora Growth (FLGC)
MKM Partners analyst William Kirk reiterated a Buy rating on Flora Growth today and set a price target of $4.00. The company’s shares closed last Tuesday at $0.88, close to its 52-week low of $0.59.
According to TipRanks.com, Kirk has 0 stars on 0-5 stars ranking scale with an average return of
Flora Growth has an analyst consensus of Moderate Buy, with a price target consensus of $3.28.
See Insiders’ Hot Stocks on TipRanks >>
RenovoRx (RNXT)
In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on RenovoRx, with a price target of $9.00. The company’s shares closed last Tuesday at $2.56, close to its 52-week low of $1.50.
According to TipRanks.com, McCarthy has 0 stars on 0-5 stars ranking scale with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for RenovoRx with a $9.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on FLGC:
